PROK
Income statement / Annual
Last year (2023), ProKidney Corp.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, ProKidney Corp.'s net income was -$35.47 M.
See ProKidney Corp.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$3.17 M |
$3.04 M |
$1.98 M |
$0.00 |
$0.00 |
| Gross Profit |
-$3.17 M |
-$3.04 M |
-$1.98 M |
$0.00 |
$0.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$106.71 M
|
$82.07 M
|
$46.26 M
|
$21.04 M
|
$75.22 M
|
| General & Administrative
Expenses |
$43.75 M
|
$70.94 M
|
$8.86 M
|
$5.98 M
|
$4.16 M
|
| Selling & Marketing
Expenses |
-$3.17 M
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$41.65 M
|
$70.94 M
|
$8.86 M
|
$5.98 M
|
$4.16 M
|
| Other Expenses |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Operating Expenses |
$148.35 M |
$153.01 M |
$55.11 M |
$27.02 M |
$79.38 M |
| Cost And Expenses |
$151.52 M |
$153.01 M |
$55.11 M |
$27.02 M |
$79.38 M |
| Interest Income |
$22.08 M |
$5.98 M |
$2,000.00 |
$43,000.00 |
$126.00 |
| Interest Expense |
$12,000.00 |
$215,000.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$3.17 M
|
$3.04 M
|
$1.98 M
|
$964,000.00
|
$867,000.00
|
| EBITDA |
-$148.35 M
|
-$143.99 M
|
-$53.13 M
|
-$26.02 M
|
-$18.29 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$22.07 M
|
$5.77 M
|
$2,000.00
|
$43,000.00
|
-$60.10 M
|
| Income Before Tax |
-$129.45 M |
-$147.24 M |
-$55.11 M |
-$26.98 M |
-$79.25 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$6.00 M |
$896,000.00 |
$38,000.00 |
-$232,000.00 |
$361,000.00 |
| Net Income |
-$35.47 M |
-$148.14 M |
-$55.15 M |
-$26.75 M |
-$79.62 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-0.57 |
-2.41 |
-0.3 |
-0.14 |
-1.01 |
| EPS Diluted |
-0.57 |
-2.41 |
-0.3 |
-0.14 |
-1.01 |
| Weighted Average Shares
Out |
$61.71 M
|
$61.54 M
|
$186.50 M
|
$186.50 M
|
$78.53 M
|
| Weighted Average Shares
Out Diluted |
$61.71 M
|
$61.54 M
|
$186.50 M
|
$186.50 M
|
$78.53 M
|
| Link |
|
|
|
|
|
